A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway

Journal of Biological Chemistry

Volumn 288, Issue 5, 2013, Pages 3406-3418

  Cho, Joon Ho ^a   Dimri, Manjari ^a   Dimri, Goberdhan P ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOACTIVATION; CANCER CELLS; CELLULAR HOMEOSTASIS; FEED-BACK LOOP; POLYCOMB GROUP PROTEINS; POSITIVE FEEDBACK LOOP; SIGNALING PATHWAYS; STEM CELL PHENOTYPES; UP-REGULATION; WNT PATHWAY; WNT SIGNALING PATHWAYS;

PIGMENTS; PROTEINS; STEM CELLS;

SIGNALING;

BMI1 PROTEIN; DICKKOPF 1 PROTEIN; DICKKOPF 2 PROTEIN; DICKKOPF 3 PROTEIN; DICKKOPF PROTEIN; GLYCOPROTEIN; MYC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BMI1 GENE; CANCER CELL; CANCER STEM CELL; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; E BOX ELEMENT; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; WNT SIGNALING PATHWAY;

BREAST NEOPLASMS; CELL LINE; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; PHENOTYPE; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB-GROUP PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84873320012     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.422931     Document Type: Article

References (42)

1. Sparmann, A., and Van Lohuizen, M. (2006) Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6, 846-856
2. Glinsky, G. V., Berezovska, O., and Glinskii, A. B. (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Investig. 115, 1503-1521
3. Guo, W. J., Zeng, M. S., Yadav, A., Song, L. B., Guo, B. H., Band, V., and Dimri, G. P. (2007) Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res. 67, 5083-5089
4. Kim, J. H., Yoon, S. Y., Jeong, S. H., Kim, S. Y., Moon, S. K., Joo, J. H., Lee, Y., Choe, I. S., and Kim, J. W. (2004) Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13, 383-388
5. Datta, S., Hoenerhoff, M. J., Bommi, P., Sainger, R., Guo, W. J., Dimri, M., Band, H., Band, V., Green, J. E., and Dimri, G. P. (2007) Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res. 67, 10286-10295
6. Hoenerhoff, M. J., Chu, I., Barkan, D., Liu, Z. Y., Datta, S., Dimri, G. P., and Green, J. E. (2009) BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 28, 3022-3032
7. Lessard, J., and Sauvageau, G. (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260
8. Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., Van Lohuizen, M., and Marino, S. (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337-341
9. Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N. S., Jackson, K. W., Suri, P., and Wicha, M. S. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063-6071
10. Molofsky, A. V., He, S., Bydon, M., Morrison, S. J., and Pardal, R. (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19, 1432-1437
11. Molofsky, A. V., Pardal, R., Iwashita, T., Park, I. K., Clarke, M. F., and Morrison, S. J. (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967
12. Sangiorgi, E., and Capecchi, M. R. (2008) Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915-920
13. Lobo, N. A., Shimono, Y., Qian, D., and Clarke, M. F. (2007) The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23, 675-699
14. Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., Dirbas, F. M., Somlo, G., Pera, R. A., Lao, K., and Clarke, M. F. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603
15. Moon, J. H., Heo, J. S., Kim, J. S., Jun, E. K., Lee, J. H., Kim, A., Kim, J., Whang, K. Y., Kang, Y. K., Yeo, S., Lim, H. J., Han, D. W., Kim, D. W., Oh, S., Yoon, B. S., Schöler, H. R., and You, S. (2011) Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res. 21, 1305-1315
16. Onder, T. T., Kara, N., Cherry, A., Sinha, A. U., Zhu, N., Bernt, K. M., Cahan, P., Marcarci, B. O., Unternaehrer, J., Gupta, P. B., Lander, E. S., Armstrong, S. A., and Daley, G. Q. (2012) Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598-602
17. Glinsky, G. V. (2005) Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle 4, 1171-1175
18. Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C, Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J. C, Hansen, K. H., and Helin, K. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are dis-associated in senescent cells. Genes Dev. 21, 525-530
19. Itahana, K., Zou, Y., Itahana, Y., Martinez, J. L., Beausejour, C, Jacobs, J. J., Van Lohuizen, M., Band, V., Campisi, J., and Dimri, G. P. (2003) Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23, 389-401
20. Chatoo, W., Abdouh, M., David, J., Champagne, M. P., Ferreira, J., Rodier, F., and Bernier, G. (2009) The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J. Neurosci. 29, 529-542
21. Jacobs, J. J., Kieboom, K., Marino, S., De Pinho, R. A., and Van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168
22. Tschen, S. I., Dhawan, S., Gurlo, T., and Bhushan, A. (2009) Age-dependent decline in β-cell proliferation restricts the capacity of β-cell regeneration in mice. Diabetes 58, 1312-1320
23. Guo, W. J., Datta, S., Band, V., and Dimri, G. P. (2007) Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol. Biol. Cell 18, 536-546
24. Barker, N., and Clevers, H. (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev. Drug Discov. 5, 997-1014
25. Moon, R. T., Kohn, A. D., De Ferrari, G. V., and Kaykas, A. (2004) WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701
26. Wilkins, J. A., and Sansom, O. J. (2008) c-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res. 68, 4963-4966
27. Dimri, G. P., Martinez, J. L., Jacobs, J. J., Keblusek, P., Itahana, K., Van Lohuizen, M., Campisi, J., Wazer, D. E., and Band, V. (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62, 4736-4745
28. Sahasrabuddhe, A. A., Dimri, M., Bommi, P. V., and Dimri, G. P. (2011) βTrCP regulates BMI1 protein turnover via ubiquitination and degradation. Cell Cycle 10, 1322-1330
29. Dimri, M., Naramura, M., Duan, L., Chen, J., Ortega-Cava, C, Chen, G., Goswami, R., Fernandes, N., Gao, Q., Dimri, G. P., Band, V., and Band, H. (2007) Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res. 67, 4164-4172
30. Li, S. K., Smith, D. K., Leung, W. Y., Cheung, A. M., Lam, E. W., Dimri, G. P., and Yao, K. M. (2008) FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J. Biol. Chem. 283, 16545-16553
31. Yadav, A. K., Sahasrabuddhe, A. A., Dimri, M., Bommi, P. V., Sainger, R., and Dimri, G. P. (2010) Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain. Mol. Cancer 9, 158
32. Ginestier, C, Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M. S., and Dontu, G. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567
33. Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., and Wicha, M. S. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270
34. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 3983-3988
35. Richly, H, Aloia, L., and Di Croce, L. (2011) Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2, e204
36. Cheng, A. S., Lau, S. S., Chen, Y., Kondo, Y., Li, M. S., Feng, H., Ching, A. K., Cheung, K. F., Wong, H. K., Tong, J. H, Jin, H, Choy, K. W., Yu, J., To, K. F., Wong, N., Huang, T. H., and Sung, J. J. (2011) EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71, 4028-4039
37. Shi, B., Liang, J., Yang, X., Wang, Y., Zhao, Y., Wu, H., Sun, L., Zhang, Y., Chen, Y., Li, R., Zhang, Y., Hong, M., and Shang, Y. (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell. Biol. 27, 5105-5119
38. Hussain, M., Rao, M., Humphries, A. E., Hong, J. A., Liu, F., Yang, M., Caragacianu, D., and Schrump, D. S. (2009) Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res. 69, 3570-3578
39. Niehrs, C. (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25, 7469-7481
40. Yu, T., Chen, X., Zhang, W., Colon, D., Shi, J., Napier, D., Rychahou, P., Lu, W., Lee, E. Y., Weiss, H. L., Evers, B. M., and Liu, C. (2012) Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer. J. Biol. Chem. 287, 3760-3768
41. González-Sancho, J. M., Aguilera, O., García, J. M., Pendás-Franco, N., Peña, C, Cal, S., García De Herreros, A., Bonilla, F., and Muñoz, A. (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24, 1098-1103
42. Niida, A., Hiroko, T., Kasai, M., Furukawa, Y., Nakamura, Y., Suzuki, Y., Sugano, S., and Akiyama, T. (2004) DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene 23, 8520-8526